跳至主要内容
临床试验/NCT04742348
NCT04742348撤回4 期

Research on Translational Outcomes of Alcohol (Project RETRO)

University of Washington0 个研究点开始时间: 2023年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
撤回
主要终点
Alcohol Consumption

研究概览

简要总结

The primary aim of the current study is to assess the effect of a single dose of carbidopa-levodopa on ad libitum alcohol consumption and alcohol craving in young adults with a history of binge drinking.

详细描述

This is a small (N = 42) 2-arm, double-blind, randomized controlled pilot study to assess the effect of a single dose of immediate release carbidopa-levodopa (50mg/500mg) to acutely reduce alcohol consumption and craving in college students with a history of heavy episodic drinking. Participants will be between 21-24 years old from 2- and 4- year colleges in the Seattle Metropolitan area. Interested students will contact the study line and provide verbal consent to be sent a link to an online screening survey. Eligible participants will be scheduled to come in for the ad libitum alcohol administration. Participants will receive either the carbidopa-levodopa or a placebo and complete the alcohol administration protocol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
21 Years 至 24 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Enrolled in 2- or 4-year college program
  • Currently living in the Seattle Metropolitan area
  • Have at least two or more episodes of heavy episodic drinking (4/5 or more drinks in a 2 hours for women/men) in the past 30 days.

排除标准

  • Exclusion criteria include:
  • past-month severe alcohol or other substance use disorders,
  • mood or anxiety disorder
  • suicidal ideation
  • risk of psychotic disorders
  • excessive alcohol use reaching a Blood Alcohol Level greater than .30%
  • history of serious medical conditions, regular use of prescription psychotropic or pain medication
  • history of negative reactions to alcohol
  • history of treatment for alcohol use disorder
  • pregnancy or nursing.
  • use of non-selective monoamine oxidase inhibitors in the past 2 weeks.
  • narrow-angle glaucoma
  • undiagnosed skin lesions,
  • have a history of melanoma, cardiac issues or peptic ulcer.
  • Currently taking or prescribed any form of levodopa or D2 agonists, D2 antagonists, isoniazid, methylphenidate, bupropion, Viagra, or phosphodiesterase inhibitors.

研究组 & 干预措施

Control, Placebo

Placebo Comparator

Similar looking tablet(s) to active drug will be administered in a single dose to those who are randomly assigned to this group.

干预措施: Placebo (Drug)

Active Drug, Carbidopa + Levodopa

Experimental

Single dose of immediate release carbidopa-levodopa (50mg/500mg).

干预措施: Carbidopa Levodopa (Drug)

结局指标

主要结局

Alcohol Consumption

时间窗: 1 hour

Number of alcoholic drinks consumed

Alcohol Craving

时间窗: 30 minutes in to alcohol administration

Amount of alcohol craving as assessed by the Alcohol Urge Questionnaire by Bohn, Krahn \& Staehler (1995)

次要结局

  • Alcohol craving(At the end of alcohol administration. Alcohol administration is 1 hour.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Brittney Hultgren

Acting Assistant Professor Department of Psychiatry and Behavioral Sciences

University of Washington

相似试验

Research on Translational Outcomes of Alcohol... | 临床试验